`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`1 Case IPR2015-01818 has been joined with this proceeding.
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`
`AMNEAL PHARMACEUTICALS LLC, PAR PHARMACEUTICAL, INC.
`and WOCKHARDT BIO AG,
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`
`_____________________
`
`Case IPR2015-005541
`Patent 7,668,730 B2
`_____________________
`
`PETITIONERS’ NOTICE OF DEPOSITION OF
`BRYAN BERGERON, MD, FACMI PURSUANT TO 37 C.F.R. § 42.53(D)
`
`
`
`IPR2015-00554
` Patent No. 7,668,730 B2
`Petitioners’ Notice of Deposition
`
`PLEASE TAKE NOTICE THAT, pursuant to 37 C.F.R. § 42.53(d)(4),
`
`Petitioners Par Pharmaceutical,
`
`Inc., Wockhardt Bio AG, and Amneal
`
`Pharmaceuticals LLC, by and through their attorneys, will conduct cross-
`
`examination by deposition of Patent Owner’s Declarant, Bryan Bergeron, MD,
`
`FACMI. Dr. Bergeron’s deposition will take place, as agreed to by counsel for the
`
`parties pursuant to 37 C.F.R. § 42.53(d)(1), beginning on January 21, 2016, at 9:00
`
`am (eastern time), at the offices of Quinn Emanuel Urquhart & Sullivan LLP, 51
`
`Madison Avenue, 22nd Floor, New York, New York 10010.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded stenographically.
`
`
`Respectfully Submitted,
`
`
`
`
`Bradford C. Frese
`Registration No. 69,772
`Attorney for Petitioners Par
`Pharmaceutical, Inc. and Amneal
`Pharmaceuticals LLC
`
`
`
`
`
`Date: January 11, 2016
`ARENT FOX LLP
`1717 K Street, NW
`Washington, DC 20006
`202.857.6000
`XYREM@arentfox.com
`
`
`
`
`
`
`
`
`CERTIFICATION OF SERVICE (37 C.F.R. §§ 42.6(e), 42.105(a))
`
`IPR2015-00554
` Patent No. 7,668,730 B2
`Certificate of Service
`
`
`The undersigned hereby certifies that the above-captioned “Petitioners’
`
`Notice of Deposition of Bryan Bergeron, MD, FACMI Pursuant to 37 C.F.R. §
`
`42.53(D)”, was served in its entirety on January 11, 2016, upon the following
`
`parties via Electronic Mail:
`
`F. Dominic Cerrito
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`NickCerrito@quinnemanuel.com
`
`
`John V. Biernacki
`Jones Day
`North Point
`901 Lakeside Avenue
`Cleveland, OH 44114
`JVBiernacki@JonesDay.Com
`
`
`
`
`
`Bradford C. Frese
`Registration No. 69,772
`Attorney for Petitioner Par
`Pharmaceutical, Inc. and Amneal
`Pharmaceuticals LLC
`
`Date: January 11, 2016
`ARENT FOX LLP
`1717 K Street, NW
`Washington, DC 20006
`202.857.6000
`XYREM@arentfox.com